tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Evolus (EOLS): Maintaining Hold Amid Softer Aesthetic Injectables Demand and Macro Headwinds
PremiumRatingsEvolus (EOLS): Maintaining Hold Amid Softer Aesthetic Injectables Demand and Macro Headwinds
19d ago
Evolus price target lowered to $19 from $20 at Mizuho
Premium
The Fly
Evolus price target lowered to $19 from $20 at Mizuho
1M ago
Evolus’s Strategic Growth and Market Resilience Drive Buy Rating
Premium
Ratings
Evolus’s Strategic Growth and Market Resilience Drive Buy Rating
1M ago
Evolus, Inc. Reports Strong Q3 2025 Growth
PremiumCompany AnnouncementsEvolus, Inc. Reports Strong Q3 2025 Growth
2M ago
Evolus sees FY25 revenue $295M-$305M, consensus $296.03M
Premium
The Fly
Evolus sees FY25 revenue $295M-$305M, consensus $296.03M
2M ago
Evolus reports Q3 EPS (24c), consensus (18c)
Premium
The Fly
Evolus reports Q3 EPS (24c), consensus (18c)
2M ago
Evolus appoints Tatjana Mitchell as CFO
PremiumThe FlyEvolus appoints Tatjana Mitchell as CFO
4M ago
Evolus announces Evolysse Sculpt trial meets primary endpoint
Premium
The Fly
Evolus announces Evolysse Sculpt trial meets primary endpoint
5M ago
Evolus submits Evolysse premarket approval application to FDA
Premium
The Fly
Evolus submits Evolysse premarket approval application to FDA
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100